相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clinical Pharmacology of the Reversible and Potent P2Y12 Receptor Antagonist ACT-246475 After Single Subcutaneous Administration in Healthy Male Subjects
Pierre-Eric Juif et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2019)
Successes, failures, and future prospects of prodrugs and their clinical impact
Anas Najjar et al.
EXPERT OPINION ON DRUG DISCOVERY (2019)
Spotlight on aldoxorubicin (INNO-206) and its potential in the treatment of soft tissue sarcomas: evidence to date
Lee D. Cranmer
ONCOTARGETS AND THERAPY (2019)
An Intratumor Pharmacokinetic/Pharmacodynamic Model for the Hypoxia-Activated Prodrug Evofosfamide (TH-302): Monotherapy Activity is Not Dependent on a Bystander Effect
Cho Rong Hong et al.
NEOPLASIA (2019)
Tardive Dyskinesia: Treatment Update
Divya Arya et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2019)
The prodrug approach in the era of drug design
Anas Najjar et al.
EXPERT OPINION ON DRUG DELIVERY (2019)
2018 FDA drug approvals
Asher Mullard
NATURE REVIEWS DRUG DISCOVERY (2019)
ONECUT2 is a driver of neuroendocrine prostate cancer
Haiyang Guo et al.
NATURE COMMUNICATIONS (2019)
Selexipag in the management of pulmonary arterial hypertension: an update
J. Gerry Coghlan et al.
DRUG HEALTHCARE AND PATIENT SAFETY (2019)
Modeling and Simulation of Pretomanid Pharmacokinetics in Pulmonary Tuberculosis Patients
Michael A. Lyons
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Latanoprostene Bunod Ophthalmic Solution 0.024%: A Review in Open-Angle Glaucoma and Ocular Hypertension
Sheridan M. Hoy
DRUGS (2018)
Telotristat Ethyl: A Review in Carcinoid Syndrome Diarrhoea
Katherine A. Lyseng-Williamson
DRUGS (2018)
Fostemsavir: a new CD4 attachment inhibitor
Pedro Cahn et al.
CURRENT OPINION IN HIV AND AIDS (2018)
Sigma Receptors as Endoplasmic Reticulum Stress Gatekeepers and their Modulators as Emerging New Weapons in the Fight Against Cancer
Anna Tesei et al.
FRONTIERS IN PHARMACOLOGY (2018)
Targeted hypoxia reduction restores T cell infiltration and sensitizes prostate cancer to immunotherapy
Priyamvada Jayaprakash et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Management of Hepatitis B Virus Infection: 2018 Guidelines from the Canadian Association for the Study of the Liver and Association of Medical Microbiology and Infectious Disease Canada
Carla S. Coffin et al.
CANADIAN LIVER JOURNAL (2018)
Warfarin: The End or the End of One Size Fits All Therapy?
Munir Pirmohamed
JOURNAL OF PERSONALIZED MEDICINE (2018)
Emergency Use of Uridine Triacetate for the Prevention and Treatment of Life-Threatening 5-Fluorouracil and Capecitabine Toxicity
Wen Wee Ma et al.
CANCER (2017)
The discovery and development of romidepsin for the treatment of T-cell lymphoma
Piotr Smolewski et al.
EXPERT OPINION ON DRUG DISCOVERY (2017)
2016 FDA drug approvals
Asher Mullard
NATURE REVIEWS DRUG DISCOVERY (2017)
Eslicarbazepine Acetate: A New Improvement on a Classic Drug Family for the Treatment of Partial-Onset Seizures
Graciana L. Galiana et al.
DRUGS IN R&D (2017)
Ceftaroline fosamil for community-acquired pneumonia and skin and skin structure infections: a systematic review
Maguy Saffouh El Hajj et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY (2017)
Ceftaroline for Severe Methicillin-Resistant Staphylococcus aureus Infections: A Systematic Review
Reese A. Cosimi et al.
OPEN FORUM INFECTIOUS DISEASES (2017)
Aripiprazole Lauroxil: A Review in Schizophrenia
James E. Frampton
DRUGS (2017)
Telotristat Ethyl: First Global Approval
Anthony Markham
DRUGS (2017)
The role of tenofovir alafenamide in future HIV management
A. Antela et al.
HIV MEDICINE (2016)
2015 FDA drug approvals
Asher Mullard
NATURE REVIEWS DRUG DISCOVERY (2016)
Tafenoquine and its potential in the treatment and relapse prevention of Plasmodium vivax malaria: the evidence to date
Yehenew A. Ebstie et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2016)
Critical evaluation of latanoprostene bunod in the treatment of glaucoma
Giancarlo A. Garcia et al.
CLINICAL OPHTHALMOLOGY (2016)
Sacubitril/Valsartan (Entresto) for Heart Failure
Mark Abramowicz et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
4-((R)-2-{[6-((S)-3-Methoxypyrrolidin-1-yl)-2-phenylpyrimidine-4-carbonyl]amino}-3-phosphonopropionyl)piperazine-1-carboxylic Acid Butyl Ester (ACT-246475) and Its Prodrug (ACT-281959), a Novel P2Y12 Receptor Antagonist with a Wider Therapeutic Window in the Rat Than Clopidogrel
Eva Caroff et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
BMS-663068, a safe and effective HIV-1 attachment inhibitor
Ester Ballana et al.
LANCET HIV (2015)
Safety and efficacy of the HIV-1 attachment inhibitor prodrug BMS-663068 in treatment-experienced individuals: 24 week results of AI438011, a phase 2b, randomised controlled trial
Jacob P. Lalezari et al.
LANCET HIV (2015)
Tedizolid Phosphate for the Management of Acute Bacterial Skin and Skin Structure Infections: Efficacy Summary
William O'Riordan et al.
CLINICAL INFECTIOUS DISEASES (2014)
Eslicarbazepine acetate: An update on efficacy and safety in epilepsy
Alberto Verrotti et al.
EPILEPSY RESEARCH (2014)
TEDIZOLID PHOSPHATE FOR THE TREATMENT OF ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS
J. Gras
DRUGS OF TODAY (2014)
Aripiprazole A Review of its Use in the Management of Schizophrenia in Adults
Jamie D. Croxtall
CNS DRUGS (2012)
Anti-amnesic and neuroprotective potentials of the mixed muscarinic receptor/sigma1 (σ1) ligand ANAVEX2-73, a novel aminotetrahydrofuran derivative
Vanessa Villard et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
The role of proximity orientation in intramolecular proton transfer reactions
Rafik Karaman
COMPUTATIONAL AND THEORETICAL CHEMISTRY (2011)
Pharmacokinetic evaluation of fosaprepitant dimeglumine
Francheska Colon-Gonzalez et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2010)
Mechanism of Activation of PSI-7851 and Its Diastereoisomer PSI-7977
Eisuke Murakami et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Primaquine revisited six decades after its discovery
Nuno Vale et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2009)
An Oxyferrous Heme/Protein-based Radical Intermediate Is Catalytically Competent in the Catalase Reaction of Mycobacterium tuberculosis Catalase-Peroxidase (KatG)
Javier Suarez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles
H. A. Nasrallah
MOLECULAR PSYCHIATRY (2008)
Phase I and pharmacokinetic study of the (6-maleimidocaproyl)hydrazone derivative of doxorubicin
Clemens Unger et al.
CLINICAL CANCER RESEARCH (2007)
Selective intracellular activation of a novel prodrug of the human immunodeficiency virus reverse transcriptase inhibitor tenofovir leads to preferential distribution and accumulation in lymphatic tissue
WA Lee et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
分享论文
